Semiconductor and healthcare names are dominating unusual options activity Monday. ORTEX screening shows NVDA topping the list for negative options bets over the past seven days. The debate over whether NVDA should be allowed to sell chips to China — reignited by Chamath Palihapitiya — is keeping options traders on edge.
MACOM Technology Solutions ranks first for overall options score this week. The stock is up 119% year-to-date. Heavy call-side activity follows MTSI's run, with its next earnings call acting as a near-term catalyst.
MaxLinear stands out even more sharply. The semiconductor name is up 430% year-to-date. Options volume has spiked alongside the price move. The return potential sits at -46%, flagging analyst caution against the rally.
Healthcare is another live area. CVS Health ranks in the top five for options score. The stock is up 21% year-to-date. Active expiries run through June and July, suggesting traders are positioning around a potential re-rating.
GameStop carries 17.9 days to cover — the highest of any name in this screen. Options expiries are sparse, running only to July. With a short score of 77, GME remains a squeeze candidate that options traders watch closely.
Macro flow is also influencing positioning. Treasury Secretary Bessent issued a 30-day license allowing vulnerable nations to access Russian oil. SPY options saw a burst of activity on the news. Iran tensions continue to push defense and energy names into the options spotlight.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
